Brief: Mangoceuticals, Inc. Announces Percent Patent Filing For MGX-0024 Antiviral Technology To Include Inhibiting Respiratory Or Orally Acquired Virus Infection In Animals Or Birds
06/03/2026 21:02
March 6 (Reuters) - Mangoceuticals Inc MGRX.O: MANGOCEUTICALS, INC. ANNOUNCES PERCENT PATENT FILING FOR MGX-0024 ANTIVIRAL TECHNOLOGY TO INCLUDE INHIBITING RESPIRATORY OR ORALLY ACQUIRED VIRUS INFECTION IN ANIMALS OR BIRDS Source text: ID:nGNX54ZlHw Further company coverage: MGRX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mangoceuticals
See all newsBrief: Mangoceuticals And Nuclea Energy Terminate Business Combination Agreement On August 19
Brief: Mangoceuticals Inc.’S Merger Partner, Nuclea Energy, Inc., Enters Into Definitive Agreement To Acquire Moltex Energy’S Advanced Nuclear Technology Assets
NASDAQ RESUMED AT 10:35 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:30 AM
NASDAQ RESUMED AT 10:27 AM